Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis

Annals of Medicine

Volumn 40, Issue 5, 2008, Pages 383-394

  Musso, Giovanni ^a   Gambino, Roberto ^b   De Michieli, Franco ^b   Biroli, Giampaolo ^b   Fagá, Emanuela ^b   Pagano, Gianfranco ^b   Cassader, Maurizio ^b  

^a GRADENIGO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Adiponectin; GGT; Lipemia; Oxidized LDL; TAS; VLDL subfractions

Indexed keywords

ADIPOCYTOKINE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ANTIOXIDANT; OXIDIZING AGENT;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; LIPID STORAGE; LIPOPROTEIN METABOLISM; LIVER DISEASE; MALE; NON ALCOHOLIC STEATOHEPATITIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; FAT INTAKE; HOSPITALIZATION; INTESTINE; LIVER; METABOLISM; PATHOLOGY;

ADIPOKINES; ADULT; ANTIOXIDANTS; DIETARY FATS; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INTESTINES; LIPID PEROXIDATION; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LIVER; MALE; OXIDANTS; POSTPRANDIAL PERIOD; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 44949095286     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890801946515     Document Type: Article

References (45)

1. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, et al. Non-alcoholic steatohepatitis, insulin resistance and metabolic syndrome: further evidence for an etiologic association. Hepatology. 2002;35:367-72.
2. Musso G, Cassader M, Gambino R, Durazzo M, Pagano G. Association between postprandial LDL conjugated dienes and the severity of liver fibrosis in NASH. (Letter). Hepatology. 2006;43:1169-70.
3. Videla LA, Rodrigo R, Orellana M, Fernandez V, Tapia G, Quinones L, et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond). 2004;106:261-8.
4. Horoz M, Bolukbas C, Bolubkas FF, Sabuncu T, Aslan M, Sarifakiogullari S, et al. Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis. BMC Gastroenterol. 2005;5:35.
5. Arsov T, Carter CZ, Nolan CJ, Petrovsky N, Goodnow CC, Teoh NC, et al. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. Biochem Biophys Res Comm. 2006;342:1152-9.
6. Westerbacka J, Lammi K, Hakkinen AM, Rissanen A, Salminen I, Aro A, et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab. 2005;90:2804-9.
7. Pedrini MT, Niederwanger A, Kranebitter M, Tautermann C, Ciardi C, Tatarczyk T, et al. Postprandial lipeemia induces an acute decrease of insulin sensitivity in healthy men independently of plasma NEFA levels. Diabetologia. 2006;49:1612-8.
8. Owens D. The extended postprandial phase in diabetes. Biochem Soc Transact. 2003;31:1085-9.
9. Dersch K, Ichijo H, Bhakdi S, Husman M. Fatty acids liberated from low-density lipoprotein trigger endothelial apoptosis via mitogen-activated protein kinases. Cell Death Differ. 2005;12:1107-14.
10. Targher G. Association between liver histology and early carotid atherosclerosis in patients with nonalcoholic fatty liver disease (Letter). Hepatology. 2005;42:974-5.
11. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343-51.
12. Holt HB, Wild SH, Wood PJ, Zhang J, Darekar AA, Dewbury K, et al. Non-esterified fatty acid concentration are independently associated with hepatic steatosis in obese subjects. Diabetologia. 2006;49:141-8.
13. Ravikumar B, Carey PE, Snaar JEM, Deelchand DK, Cook DB, Neely RDG, et al. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab. 2005;288:E789-97.
14. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3-16.
15. Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol. 1997;26 Suppl 1:S152-60.
16. Salvini S, Parpinel M, Gnagnarella P, Maisonneuve P, Turrini A. Banca Dati di Composizione degli Alimenti per Studi Epidemiologici in Italia. Istituto Europeo di Oncologia. www.nutrizione.com/pubs/tabelle-composizione-alimenti. aspx Reggio Calabria: Laruffa 1998.
17. Nunez C, Gallagher D, Visser M. Bioimpedance analysis: evaluation of leg-to-leg system based on pressure contact footpad electrodes. Med Sci Sports Exerc. 1997;29:524-31.
18. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-70.
19. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in Nonalcoholic Steatohepatitis. Hepatology. 2003;37:909-16.
20. Duez H, Lamarche B, Uffelman KD, Valero R, Cohn JS, Lewis GF. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006;26:1357-63.
21. Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, et al. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids. 2002;36:1117-24.
22. Stocks SG, Miller NE. Capillary electrophoresis to monitor the oxidative modification of LDL. J Lipid Res. 1998;39:1305-9.
23. On YK, Park R, Hyon MS, Kim SK, Kwon YJ. Are low total serum antioxidant status and elevated levels of C-reactive protein and monocyte chemotactic protein-1 associated with cardiac syndrome X? Circ J. 2005;69:1212-7.
24. Belo L, Caslake M, Santos-Silva A, Castro EM, Pereira-Leite L, Quintanilha A, et al. LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis. 2004;177:391-9.
25. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545-8.
26. Grundy SM, Brewer B, Cleeman JI, Smith SC, Lenfant C. NHLBI/AHA Conference Proceedings. Definition of the metabolic syndrome. Circulation. 2004;109:433-8.
27. LARN - Livelli di assunzione giornalieri raccomandati di nutrienti per la popolazione italiana. available at www.sinu.it (Società di Nutrizione Umana, revisione 1996).
28. Lu L, Zeng M, Li J, Hua J, Fan J, Fan Z, et al. Effects of Kupffer cells stimulated by triglyceride and very low-density lipoprotein on proliferation of rat hepatic stellate cells. Chin Med. 1999;112:325-9.
29. Ustundag Y, Ozer IO, Yenidunia S. Oxidized low density lipoprotein in liver tissue samples of our NASH patients, alcoholic and chronic viral hepatitis cases. Gastroenterology. 2002;57:203.
30. Ikura Y, Ohsaka M, Fukushima M, Ryo Y, Muraguchi T. Increased expression of the scavenger receptor CD36 in activated stellate cells in steatotic livers; its relation to fibrotic process in non-alcoholic fatty liver disease. Hepatology. 2005;42 S1:620A.
31. Malhi H, Bronk SF, Werneburg NW, Gores G. Free fatty acids induce JNK dependent hepatocyte lipoapoptosis. J Biol Chem. 2006;281:12093-101.
32. Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology. 2006;43:163-72.
33. Turgut O, Yilmaz A, Yalta K, Karadas F, Yilmaz MB. Glutamyltransferase is a promising biomarker for cardiovascular risk. Med Hypoth. 2006;67:1060-4.
34. Andrè P, Balkau B, Born C, Charles MA, Eschwege E, DESIR study group. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the DESIR cohort. Diabetologia. 2006;49:2599-603.
35. Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, et al. Lipoprotein- and LDL-associated serum γ-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis. 2006;186:80-5.
36. Papadakis JA, Ganotakis ES, Jagroop IA, Winder AF, Mikhailidis DP. Statin+fibrate combination therapy: fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease. Int J Cardiol. 1999;69:237-44.
37. Lee DH, Jacob DR, Gross M, Kiefe I, Roseman J, Lewis CE, et al. γ-Glutamyltransferase is a predictor of incident diabetes and hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003;49:1358-66.
38. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, et al. Liver enzymes, the metabolic syndrome, and incident diabetes. The Mexico City Diabetes Study. Diabetes Care. 2005;28:1757-62.
39. Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P, Sundvall J, et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28838 middle-aged men and women. Eur Heart J. 2006;27:2170-6.
40. Will Y, Fischer KA, Horton RA, Kaetzel RS, Brown MK, Hedstrom O, et al. Glutamyltranspeptidase-deficient knockout mice as a model to study the relationship between glutathione status, mitochondrial function and cellular function. Hepatology. 2000;32:740-9.
41. Paolicchi A, Tongiani R, Tonarelli P, Comporti M, Pompella A. Gamma-glutamyl transpeptidase-dependent lipid peroxidation in isolated and HepG2 hepatoma cells. Free Radic Biol Med. 1997;22:853-60.
42. Paolicchi A, Mintoti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyltranspeptidase-dependent iron reduction and LDL oxidation - a potential mechanism in atherosclerosis. J Investig Med. 1999;47:151-60.
43. Accaoui MJ, Enoiu M, Mergny M, Masson C, Dominaci S, Wellman M, et al. Gamma-glutamyltranspeptidase-dependent glutathione catabolism results in activation of NF-kB. Biochem Biophys Res Commun. 2000;276:1062-7.
44. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen PT, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001;98:2005-10.
45. Von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care. 2004;27:2925-9.